STONY BROOK, NY--(Marketwire - April 7, 2011) - Applied DNA Sciences, Inc. (
Ms. Mead brings forensic crime laboratory experience from the Houston Police Department, and most recently, the Institute for Forensic Genetics (IFG) headquartered in Denver, Colorado. At the IFG, she instructed laboratory analysts and research assistants in forensic techniques and was responsible for the coordination of the application of ISO 17025 accreditation. She has a Master's degree in Forensic Science from Sam Houston State University (Texas).
Dr. Benjamin Liang, Chief Scientific Officer stated, "We are excited to have Breanna on board and expect her contribution to the team to respond to the growing demand for DNA anti-counterfeiting technology and forensic authentications."
The increased volume of authentications and laboratory work bears witness to the increasing demand for SigNature® DNA. It offers a flexible platform that can compliment any existing security system and it provides the most accepted forensic standard.
According to a 2011 report published by the International Chamber of Commerce (ICC), global counterfeiting losses are forecasted to grow to as high as $1.7 trillion by 2017. The economic impact of this on the US economy alone is as much as $775 billion per year, resulting in lost tax revenue and high government spending on law enforcement and health care.
About APDN
APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to www.adnas.com where APDN routinely posts all press releases.
The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN's future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN's SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.
Contact Information:
INVESTOR CONTACT:
Debbie Bailey
631-444-8090
fax: 631-444-8848
MEDIA CONTACT:
Janice Meraglia
631-444-6293
fax: 631-444-8848
FCMN Contact:
Web site: http://www.adnas.com